Aroa Biosurgery narrows loss, boosts Myriad sales as sheep stomach tech pays off

Aroa Biosurgery narrows loss, boosts Myriad sales as sheep stomach tech pays off
Aroa Biosurgery founder Brian Ward says new clinical publications should further validate the efficacy of its products. (Image: Aroa Biosurgery)
Rebecca Stevenson
Soft tissue regeneration company Aroa Biosurgery has boosted revenue and narrowed its loss. The Auckland-based company announced its result for the six months to Sept 30 on Tuesday. The ASX-listed firm said revenue increased 14% to $44.9 million, with revenue from its Myriad products rising 33% on the same period in the prior financial year to $19.7m. Aroa uses sheep stomachs to create wound repair products, including for complex wound treatment. Its proprietary soft tissue extracellular matrix helps to encourage human tissu...

More Markets

NZ stocks eke out gain as investors tread water
Markets Market Close

NZ stocks eke out gain as investors tread water

New Zealand stocks ended with a slight gain but investors were largely sidelined.

Jamie Gray 12 Dec 2025
Comvita wins breathing room from banks
Primary Sector

Comvita wins breathing room from banks

The company’s annual meeting is next week.

Riley Kennedy 12 Dec 2025
NZX Bitcoin ETF turns negative for many investors
Opinion Stock & Trade

Stock & Trade: NZX Bitcoin ETF turns negative for many investors

Bitcoin ETF party fizzles as latecomer investors face negative returns.

Stock & Trade 12 Dec 2025